Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results
| Autor: | Hiroaki Sakai, Jun Nakajima, Yasuhiro Nakashima, Toyofumi F. Chen-Yoshikawa, Keiko Ueda, Terumoto Koike, Masaru Takenaka, Junko Tokuno, Ryuta Fukai, Fumihiro Tanaka, Fumitsugu Kojima, Masashi Kobayashi, Masaaki Sato, Tomoki Nishida, Shinji Kosaka, Jin Sakamoto, Yoshito Yamada, Hiroshi Date, Nobuyuki Yoshiyasu, Kazumichi Yamamoto, Masahiro Yanagiya, Kenji Misawa, Hirokazu Yamaguchi, Shinji Shinohara |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Lung Neoplasms Ground-glass opacity Bronchoscopy medicine Humans Prospective Studies Stage (cooking) Pneumonectomy Lung cancer Lung Neoplasm Staging Retrospective Studies medicine.diagnostic_test business.industry Cancer General Medicine medicine.disease Sublobar resection medicine.anatomical_structure Multiple Pulmonary Nodules Surgery Radiology medicine.symptom Cardiology and Cardiovascular Medicine business Wedge resection (lung) |
| Zdroj: | European Journal of Cardio-Thoracic Surgery. 61:761-768 |
| ISSN: | 1873-734X 1010-7940 |
| DOI: | 10.1093/ejcts/ezab421 |
| Popis: | OBJECTIVES The short-term efficacy of virtual-assisted lung mapping (VAL-MAP), a preoperative bronchoscopic multi-spot lung-marking technique, has been confirmed in 2 prospective multicentre studies. The objectives of this study were to analyse the local recurrence and survival of patients enrolled in these studies, long-term. METHODS Of the 663 patients enrolled in the 2 studies, 559 patients’ follow-up data were collected. After excluding those who did not undergo VAL-MAP, whose resection was not for curative intent, who underwent concurrent resection without VAL-MAP, or who eventually underwent lobectomy instead of sublobar resection (i.e. wedge resection or segmentectomy), 422 patients were further analysed. RESULTS Among 264 patients with primary lung cancer, the 5-year local recurrence-free rate was 98.4%, and the 5-year overall survival (OS) rate was 94.5%. Limited to stage IA2 or less (≤2 cm in diameter; n = 238, 90.1%), the 5-year local recurrence-free and OS rates were 98.7% and 94.8%, respectively. Among 102 patients with metastatic lung tumours, the 5-year local recurrence-free rate was 93.8% and the 5-year OS rate was 81.8%. Limited to the most common (colorectal) cancer (n = 53), the 5-year local recurrence-free and OS rates were 94.9% and 82.3%, respectively. CONCLUSIONS VAL-MAP, which is beneficial in localizing small barely palpable pulmonary lesions and determining the appropriate resection lines, was associated with reasonable long-term outcomes. Subj collection 152, 1542 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|